News - Diabetes care

Platinum Equity buys J&J’s diabetes unit LifeScan for $2.1bn

Global investment firm Platinum Equity has completed the acquisition of Johnson & Johnson’s (J&J) diabetes unit, LifeScan, for about $2.1bn.

Novo Nordisk to launch connected insulin pens in early 2019

Danish healthcare firm Novo Nordisk has unveiled plans to introduce new durable, connected insulin pens in early 2019.

GE, DARPA collaborate on research of new diabetes treatments

GE Global Research has collaborated with the US Defense Advanced Research Projects Agency (DARPA) to study new treatments for diabetes.

EC approves AstraZeneca’s Bydureon BCise device for type-2 diabetes

AstraZeneca has secured marketing authorisation from the European Commission (EC) for its Bydureon BCise device to treat patients with type-2 diabetes.

ALRT signs MOU with Aspire Cerebro to bring diabetes solution to India

Medical device company ALR Technologies (ALRT) has signed a Memorandum of Understanding (MOU) with healthcare communication firm Aspire Cerebro Advertising to bring ALRT Diabetes Solution to India.

Valeritas launches V-Go Insulin delivery device in Australia

Valeritas' V-Go Wearable Insulin delivery device is now available in Australia through the company's previously disclosed exclusive distribution agreement with AMSL Diabetes.

Dexcom buys TypeZero Technologies

DexCom, a developer of continuous glucose monitoring systems for people with diabetes, has acquired TypeZero Technologies for an undisclosed amount.

Tandem Diabetes Care introduces t:slim X2 insulin pump with Basal-IQ technology in US

Medical device company Tandem Diabetes Care has launched the t:slim X2 insulin pump with Basal-IQ technology in the US.

Novo Nordisk to buy UK university biotech spin-out Ziylo

Danish healthcare company Novo Nordisk has agreed to acquire University of Bristol spin-out company Ziylo in a deal that could exceed $800m.